IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 152 filers reported holding IMMUNOVANT INC in Q2 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,437 | +61.3% | 63,469 | -20.3% | 0.12% | +74.2% |
| Q2 2023 | $1,511 | +148.5% | 79,659 | +103.3% | 0.07% | +127.6% |
| Q1 2023 | $608 | -99.9% | 39,189 | -52.6% | 0.03% | +3.6% |
| Q3 2022 | $462,000 | -6.1% | 82,741 | -34.4% | 0.03% | -24.3% |
| Q2 2022 | $492,000 | -34.5% | 126,200 | -7.4% | 0.04% | -24.5% |
| Q1 2022 | $751,000 | +147.9% | 136,327 | +374.8% | 0.05% | -52.0% |
| Q2 2021 | $303,000 | -71.8% | 28,710 | -57.2% | 0.10% | -70.3% |
| Q1 2021 | $1,076,000 | – | 67,113 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 4,448,017 | $17,347,000 | 4.39% |
| Deep Track Capital, LP | 9,455,000 | $36,875,000 | 2.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233 | $60,000,000 | 0.63% |
| Octagon Capital Advisors LP | 579,061 | $2,258,000 | 0.60% |
| Eventide Asset Management | 5,372,512 | $20,953,000 | 0.45% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 174,000 | $679,000 | 0.29% |
| Frazier Life Sciences Management, L.P. | 585,759 | $2,284,000 | 0.22% |
| BCK CAPITAL MANAGEMENT LP | 54,293 | $212,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 777,590 | $3,033,000 | 0.12% |
| Bridgefront Capital, LLC | 15,649 | $61,000 | 0.07% |